Spravato Treatment
Now Offering SPRAVATO® Treatment
When depression has not improved with traditional antidepressants, SPRAVATO® may offer another path forward.
SPRAVATO® (esketamine) is an FDA-approved prescription nasal spray for adults with treatment-resistant depression. It works differently from traditional antidepressants and is administered in a comfortable, supervised clinical setting.
Each treatment includes:
• Administration under medical supervision
• Blood pressure and safety monitoring
• A relaxing environment for treatment
• At least two hours of observation afterward
• Ongoing assessment and individualized care
Treatment is available following a comprehensive evaluation to determine eligibility.
SPRAVATO® is available only through certified treatment centers. Individual results vary. Eligibility and insurance coverage are determined on a case-by-case basis.
